dc.creatorArévalo, Bárbara
dc.creatorBedoya, Mauricio
dc.creatorKiper, Aytug K.
dc.creatorVergara, Fernando
dc.creatorRamírez, David
dc.creatorMazola, Yuliet
dc.creatorBustos, Daniel
dc.creatorZúñiga, Rafael
dc.creatorCikutovic, Rocio
dc.creatorCayo, Angel
dc.creatorRinné, Susanne
dc.creatorRamirez-Apan, M. Teresa
dc.creatorSepúlveda, Francisco V.
dc.creatorCerda, Oscar
dc.creatorLópez-Collazo, Eduardo
dc.creatorDecher, Niels
dc.creatorZúñiga, Leandro
dc.creatorGutierrez, Margarita
dc.creatorGonzález, Wendy
dc.date2022-12-29T18:24:44Z
dc.date2022-12-29T18:24:44Z
dc.date2022
dc.date.accessioned2024-05-02T20:30:13Z
dc.date.available2024-05-02T20:30:13Z
dc.identifierhttp://repositorio.ucm.cl/handle/ucm/4301
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9274550
dc.descriptionChemical structures of selective blockers of TASK channels contain aromatic groups and amide bonds. Using this rationale, we designed and synthesized a series of compounds based on 3-benzamidobenzoic acid. These compounds block TASK-1 channels by binding to the central cavity. The most active compound is 3-benzoylamino-N-(2-ethyl-phenyl)-benzamide or F3, blocking TASK-1 with an IC50 of 148 nM, showing a reduced inhibition of TASK-3 channels and not a significant effect on different K+ channels. We identified putative F3-binding sites in the TASK-1 channel by molecular modeling studies. Mutation of seven residues to A (I118A, L122A, F125A, Q126A, L232A, I235A, and L239A) markedly decreased the F3-induced inhibition of TASK-1 channels, consistent with the molecular modeling predictions. F3 blocks cell proliferation and viability in the MCF-7 cancer cell line but not in TASK-1 knockdown MCF-7 cells, indicating that it is acting in TASK-1 channels. These results indicated that TASK-1 is necessary to drive proliferation in the MCF-7 cancer cell line.
dc.languageen
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.sourceJournal of Medicinal Chemistry, 65(22), 15014-15027
dc.titleSelective TASK-1 inhibitor with a defined structure–activity relationship reduces cancer cell proliferation and viability
dc.typeArticle


Este ítem pertenece a la siguiente institución